ESC 2018: Use of SGLT2 inhibitors in clinical practice to reduce CV mortality in patients with type 2 diabetes

Published: 22 Oct 2018

  • Views:

    Views Icon 482
  • Likes:

    Heart Icon 0
Average (ratings)
No ratings
Your rating


Esc 2018: Use of sglt2 Inhibitors in Clinical Practice to Reduce CV Mortality in Patients With Type 2 Diabetes - Prof Javed Butler & Prof Stefan Anker

Filmed on-site at ESC 2018 by Radcliffe Cardiology.